未登录

M

Michał Wilk

european health center otwock

H指数:7

被引数:323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DXA-Derived Total Body Fat Percentage and Serum 25(OH)D in Overweight and Obese Children: A Cross-Sectional Study

DXA衍生全身脂肪百分比与超重和肥胖儿童血清25(OH)D的关系：一项横断面研究

IF5

2026-08-110

OA

One scenario: each doctor, each verdict. How do anesthetists identify futile therapy? A questionnaire study

一种情景：每位医生，每个诊断。麻醉师如何识别无效治疗？一项问卷调查研究

Palliative Medicine in Practice

IF0.6

2026-01-010

PRE

Futile therapy in critically ill patients from the perspective of anesthetists: a questionnaire study

危重症患者中无效治疗的观点：一项问卷调查研究

Palliative Medicine in Practice

IF0.6

2026-01-011

PRE

Prevalence and factors associated with professional burnout in Polish oncologists-results of a nationwide survey

波兰肿瘤学家的患病率和与职业倦怠相关的因素-全国性调查的结果

IF8.3

2024-02-013

OAAI

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

FRONTIERS IN ONCOLOGY

IF3.3

2023-04-033

OAAI

Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19

IF3.4

2021-04-2162

OAAI

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-0119

OAAI

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin

SCIENTIFIC REPORTS

IF3.9

2020-10-287

OAAI

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

IF8.3

2020-01-0190

OAAI